These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 14622351)

  • 1. Pathogenesis of diabetic retinopathy and the renin-angiotensin system.
    Funatsu H; Yamashita H
    Ophthalmic Physiol Opt; 2003 Nov; 23(6):495-501. PubMed ID: 14622351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the angiotensin II type 1 receptor in the pathogenesis of diabetic retinopathy: effects of blood pressure control and beyond.
    Clermont A; Bursell SE; Feener EP
    J Hypertens Suppl; 2006 Mar; 24(1):S73-80. PubMed ID: 16601577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The therapeutic implications of renin-angiotensin system blockade in diabetic retinopathy.
    Jeganathan VS
    Curr Pharm Biotechnol; 2011 Mar; 12(3):392-5. PubMed ID: 20939795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The interaction between the renin-angiotensin system and vascular endothelial growth factor in the pathogenesis of retinal neovascularization in diabetes.
    Wilkinson-Berka JL; Kelly DJ; Gilbert RE
    J Vasc Res; 2001; 38(6):527-35. PubMed ID: 11740151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New approaches to the treatment of diabetic retinopathy.
    Porta M; Maldari P; Mazzaglia F
    Diabetes Obes Metab; 2011 Sep; 13(9):784-90. PubMed ID: 21535345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Tissue Renin-angiotensin System and the Chymase/angiotensin-( 1-12) Axis in the Pathogenesis of Diabetic Retinopathy.
    Ola MS; Alhomida AS; Ferrario CM; Ahmad S
    Curr Med Chem; 2017; 24(28):3104-3114. PubMed ID: 28403787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetes and retinal vascular disorders: role of the renin-angiotensin system.
    Wilkinson-Berka JL
    Expert Rev Mol Med; 2004 Jul; 6(15):1-18. PubMed ID: 15387897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin converting enzyme inhibiting therapy is associated with lower vitreous vascular endothelial growth factor concentrations in patients with proliferative diabetic retinopathy.
    Hogeboom van Buggenum IM; Polak BC; Reichert-Thoen JW; de Vries-Knoppert WA; van Hinsbergh VW; Tangelder GJ
    Diabetologia; 2002 Feb; 45(2):203-9. PubMed ID: 11935151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin and diabetic retinopathy.
    Wilkinson-Berka JL
    Int J Biochem Cell Biol; 2006; 38(5-6):752-65. PubMed ID: 16165393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The renin-angiotensin system and diabetic retinopathy.
    Kohner EM
    Klin Wochenschr; 1992; 69 Suppl 29():25-7. PubMed ID: 1614187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The retinal renin-angiotensin system: implications for therapy in diabetic retinopathy.
    Sjølie AK; Chaturvedi N
    J Hum Hypertens; 2002 Aug; 16 Suppl 3():S42-6. PubMed ID: 12140727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The changing role of the endocrinologist in the care of patients with diabetic retinopathy.
    Porta M; Taulaigo AV
    Endocrine; 2014 Jun; 46(2):199-208. PubMed ID: 24385265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The renin-angiotensin system influences ocular endothelial cell proliferation in diabetes: transgenic and interventional studies.
    Moravski CJ; Skinner SL; Stubbs AJ; Sarlos S; Kelly DJ; Cooper ME; Gilbert RE; Wilkinson-Berka JL
    Am J Pathol; 2003 Jan; 162(1):151-60. PubMed ID: 12507898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin II and vascular endothelial growth factor in the vitreous fluid of patients with diabetic macular edema and other retinal disorders.
    Funatsu H; Yamashita H; Ikeda T; Nakanishi Y; Kitano S; Hori S
    Am J Ophthalmol; 2002 Apr; 133(4):537-43. PubMed ID: 11931788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Aging and retinal vascular diseases].
    Takagi H
    Nippon Ganka Gakkai Zasshi; 2007 Mar; 111(3):207-30; discussion 231. PubMed ID: 17402563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retinal neovascularization is prevented by blockade of the renin-angiotensin system.
    Moravski CJ; Kelly DJ; Cooper ME; Gilbert RE; Bertram JF; Shahinfar S; Skinner SL; Wilkinson-Berka JL
    Hypertension; 2000 Dec; 36(6):1099-104. PubMed ID: 11116132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Renin-Angiotensin system and vascular disease in diabetes.
    Deinum J; Chaturvedi N
    Semin Vasc Med; 2002 May; 2(2):149-56. PubMed ID: 16222606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relation of ambulatory blood pressure and pulse rate to retinopathy in type 1 diabetes mellitus: the renin-angiotensin system study.
    Klein R; Moss SE; Sinaiko AR; Zinman B; Gardiner R; Suissa S; Donnelly SM; Kramer MS; Goodyer P; Strand T; Mauer M
    Ophthalmology; 2006 Dec; 113(12):2231-6. PubMed ID: 16996597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does hypertension play a role in diabetic retinopathy?
    Srivastava BK; Rema M
    J Assoc Physicians India; 2005 Sep; 53():803-8. PubMed ID: 16334627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin II and vascular endothelial growth factor in the vitreous fluid of patients with proliferative diabetic retinopathy.
    Funatsu H; Yamashita H; Nakanishi Y; Hori S
    Br J Ophthalmol; 2002 Mar; 86(3):311-5. PubMed ID: 11864890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.